Testing plasma pools for markers of viral contamination: The UK experience

Vox Sanguinis

Volumn 71, Issue 1, 1996, Pages 21-26

  Ferguson, Morag ^a   Minor, Philip D ^a   Garrett, A John ^a   Page, Mark ^a   Thorpe, Robin ^a   Barrowcliffe, Trevor ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MARKER;

ARTICLE; BLOOD; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PLASMA; PRIORITY JOURNAL; QUALITY CONTROL; SCREENING; UNITED KINGDOM; VIRUS INFECTION;

EID: 0029991556     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1996.7110021.x     Document Type: Article

References (5)

1. Linden JV: Error contributes to the risk of transmissible disease. Transfusion 1994;34:1016.
2. European Commission ad hoc Working Party on Biotechnology/Pharmacy: Note for Guidance - Plasma Pool Testing, 1994.
3. Barbara JAJ: Questions of quality: How much HBsAg is there in this sample and is our assay sensitive enough to detect it? Vox Sang 1993; 65:249-250.
4. Ferguson M, Pipkin PA, Heath AB, Minor PD: Working standards for HBsAg for use in the UK Blood Transfusion Service: Results of a collaborative study. Vox Sang 1993;65:303-308.
5. Saldanha J, Minor PD: A sensitive PCR method for detecting HCV RNA in plasma pools, blood products and single donations. J Med Virol 1994;43:72-76.